Luton, United Kingdom

Maria Grazia Carr


 

 

Average Co-Inventor Count = 10.0

ph-index = 7

Forward Citations = 187(Granted Patents)


Location History:

  • Luton, GB (2008 - 2018)
  • Cambridge, GB (2010 - 2019)

Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovator Profile: Maria Grazia Carr

Introduction: Maria Grazia Carr, based in Luton, GB, is a prominent inventor in the field of pharmaceutical sciences. With an impressive portfolio of 22 patents, Carr has made significant contributions, particularly in developing compounds with therapeutic applications.

Latest Patents: Among her latest innovative patents, Carr introduced "Biaryl pyrazoles as NRF2 regulators." This invention relates to biaryl pyrazole compounds and their pharmaceutical compositions, highlighting their potential use as NRF2 regulators. Another notable patent is on "Hydroxybenzamide derivatives and their use as inhibitors of HSP90." This patent provides novel compounds with therapeutic activity as Hsp90 inhibitors, showcasing a structure that incorporates a variety of functional groups and complex ring systems.

Career Highlights: Maria Grazia Carr has collaborated with various prestigious organizations throughout her career. She has worked extensively at Astex Therapeutics Limited, leveraging her expertise in drug development and innovation. Additionally, her tenure at The Institute of Cancer Research, known as the Royal Cancer Hospital, has allowed her to make valuable contributions to cancer research and therapeutic advancements.

Collaborations: Throughout her career, Carr has partnered with esteemed colleagues, including Valerio Berdini and Michael Alistair O'Brien. These collaborations have been instrumental in advancing her research and patent applications, contributing to innovative solutions in her field.

Conclusion: Maria Grazia Carr is a notable figure in the world of inventions, particularly in pharmaceuticals. Her extensive patent portfolio and significant contributions to leading research institutions highlight her dedication to innovation and the advancement of medical science. As she continues to develop pioneering compounds, her work remains vital in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…